GB8627656D0 - Carbamoyloxymethylalkylcarbapenem compounds - Google Patents

Carbamoyloxymethylalkylcarbapenem compounds

Info

Publication number
GB8627656D0
GB8627656D0 GB868627656A GB8627656A GB8627656D0 GB 8627656 D0 GB8627656 D0 GB 8627656D0 GB 868627656 A GB868627656 A GB 868627656A GB 8627656 A GB8627656 A GB 8627656A GB 8627656 D0 GB8627656 D0 GB 8627656D0
Authority
GB
United Kingdom
Prior art keywords
carbamoyloxymethylalkylcarbapenem
compounds
carbamoyloxymethylalkylcarbapenem compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB868627656A
Other versions
GB2183236B (en
GB2183236A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of GB8627656D0 publication Critical patent/GB8627656D0/en
Publication of GB2183236A publication Critical patent/GB2183236A/en
Application granted granted Critical
Publication of GB2183236B publication Critical patent/GB2183236B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB8627656A 1985-11-19 1986-11-19 Carbamoyloxymethylalkylcarbapenem compounds Expired GB2183236B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26073185 1985-11-19

Publications (3)

Publication Number Publication Date
GB8627656D0 true GB8627656D0 (en) 1986-12-17
GB2183236A GB2183236A (en) 1987-06-03
GB2183236B GB2183236B (en) 1989-04-12

Family

ID=17351968

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8627656A Expired GB2183236B (en) 1985-11-19 1986-11-19 Carbamoyloxymethylalkylcarbapenem compounds

Country Status (10)

Country Link
JP (1) JPS62201889A (en)
KR (1) KR870004984A (en)
AU (1) AU6534786A (en)
BE (1) BE905784A (en)
CA (1) CA1283416C (en)
CH (1) CH671580A5 (en)
DE (1) DE3639542C2 (en)
FR (1) FR2590256B1 (en)
GB (1) GB2183236B (en)
IT (1) IT1195842B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292191A1 (en) * 1987-05-21 1988-11-23 Merck & Co. Inc. 2-(Substituted methyl)-1-alkylcarbapenem derivatives
AU737502B2 (en) * 1997-08-27 2001-08-23 Merck & Co., Inc. Preparation of beta-methyl carbapenem intermediates
US6143885A (en) * 1997-08-27 2000-11-07 Merck & Co., Inc. Preparation of beta-methyl carbapenem intermediates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
EP0184844A1 (en) * 1984-12-13 1986-06-18 Merck & Co. Inc. 1-Methylcarbapenems having a 2-position substituent joined through an alkylenethio bridge

Also Published As

Publication number Publication date
IT1195842B (en) 1988-10-27
DE3639542C2 (en) 1995-07-13
GB2183236B (en) 1989-04-12
JPS62201889A (en) 1987-09-05
CH671580A5 (en) 1989-09-15
IT8667861A0 (en) 1986-11-19
KR870004984A (en) 1987-06-04
DE3639542A1 (en) 1987-05-21
CA1283416C (en) 1991-04-23
AU6534786A (en) 1987-05-21
BE905784A (en) 1987-03-16
FR2590256B1 (en) 1989-12-22
GB2183236A (en) 1987-06-03
FR2590256A1 (en) 1987-05-22

Similar Documents

Publication Publication Date Title
GB8510758D0 (en) Compounds
GB8501999D0 (en) Compounds
GB8507942D0 (en) Compounds
GB8505285D0 (en) Compounds
GB8511988D0 (en) Compounds
GB2178740B (en) Alkylcarbamoyloxymethylcephem compounds
GB2203433B (en) Trizinyl compounds
EP0199465A3 (en) Cyanoalkanimidamido compounds
GB2169897B (en) 5- halopyridine-3-carboxamide compounds
GB8515522D0 (en) Compounds
GB2170200B (en) Acylaminoalkanoyl compounds
GB8510752D0 (en) Compounds
GB2183236B (en) Carbamoyloxymethylalkylcarbapenem compounds
GB8503358D0 (en) Compounds
GB2175586B (en) Mycotrienin-related compounds
GB8509834D0 (en) Compounds
GB8514679D0 (en) Compounds
GB8508972D0 (en) Compounds
GB8506642D0 (en) Compounds
GB8502690D0 (en) Compounds
GB8511759D0 (en) Compounds
GB8512142D0 (en) Compounds
GB8513039D0 (en) Compounds
GB8510757D0 (en) Compounds
GB8510331D0 (en) Compounds

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19951119